AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study.
Hu H, Mosca R, Gomero E, van de Vlekkert D, Campos Y, Fremuth LE, Brown SA, Weesner JA, Annunziata I, d'Azzo A.
Hu H, et al.
Mol Ther Methods Clin Dev. 2021 Oct 28;23:644-658. doi: 10.1016/j.omtm.2021.10.007. eCollection 2021 Dec 10.
Mol Ther Methods Clin Dev. 2021.
PMID: 34901309
Free PMC article.